Phase 1/2a Study of RP-001 in Participants With Advanced Malignancies

Clinical trial NCT07504263 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07504263
Sponsor: Recurv Pharma Inc
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Malignancies Oncology Colorectal Cancer Pancreatic Cancer Cancer

Start date: 2026-04-23
Primary completion: 2027-12-01
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.